| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/2004 | WO2004056307A2 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | WO2004056306A2 Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases |
| 07/08/2004 | WO2004056305A2 Administration of capsaicinoids |
| 07/08/2004 | WO2004056210A1 Use of prebiotics for preventing or treating oxidation stress |
| 07/08/2004 | WO2004056209A1 Ginseng-containing agent for producing a sensation of satiety and for weight reduction |
| 07/08/2004 | WO2004056208A1 Stimulation of in vivo production of proteins with formulation comprising leucine |
| 07/08/2004 | WO2004056181A1 Organ preconditioning, arrest, protection, preservation and recovery (2) |
| 07/08/2004 | WO2004056180A1 Organ preconditioning, arrest, protection, preservation and recovery (1) |
| 07/08/2004 | WO2004050018A3 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 07/08/2004 | WO2004047756A3 Propargyl-trifluoromethoxy-amino-benzothiazole derivatives |
| 07/08/2004 | WO2004046096A3 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 07/08/2004 | WO2004045546A3 Water-soluble mesoporphyrin compounds and methods of preparation |
| 07/08/2004 | WO2004045534A3 Chroman derivatives for the reduction of inflammation symptoms |
| 07/08/2004 | WO2004045511A3 Non-steroidal farnesoid x receptor modulators |
| 07/08/2004 | WO2004045498A3 Stabilized polyester/cyanoacrylate tissue adhesive formulation |
| 07/08/2004 | WO2004045492A3 Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 07/08/2004 | WO2004045491A3 Targeted double stranded rna mediated cell killing |
| 07/08/2004 | WO2004044194A3 Calmodulin independent activation of nitric oxide synthase by nadph analogs |
| 07/08/2004 | WO2004043424A8 Method of stimulating hair growth using benzopyrans |
| 07/08/2004 | WO2004043393A3 Compositions for diabetes treatment and prophylaxis |
| 07/08/2004 | WO2004041755A3 Quinazolinone compounds as calcilytics |
| 07/08/2004 | WO2004041210A3 Antibacterial agents |
| 07/08/2004 | WO2004039377A8 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 07/08/2004 | WO2004039362A3 Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia |
| 07/08/2004 | WO2004039308A3 Quinazolinone compositions for regulation of gene expression related to pathological processes |
| 07/08/2004 | WO2004037226A3 Pharmaceutical compositions containing venlafaxine |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004037179A3 Substituted peptides useful in the treatment of alzheimer’s disease |
| 07/08/2004 | WO2004037171A3 Mitotic kinesin inhibitors |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004034990A3 Methods and compositions for use in treating cancer |
| 07/08/2004 | WO2004032882A3 Chemical compounds |
| 07/08/2004 | WO2004032876A9 Deguelin as a chemopreventive agent for lung cancer |
| 07/08/2004 | WO2004028634A9 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 07/08/2004 | WO2004028476A3 Artemisinin-derived trioxane dimers |
| 07/08/2004 | WO2004026257A3 Treatment of irritable bowel syndrome and related bowel diseases |
| 07/08/2004 | WO2004026226A3 Compounds, compositions and methods |
| 07/08/2004 | WO2004024682A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity. |
| 07/08/2004 | WO2004024128A3 Modified release ketoprofen dosage form |
| 07/08/2004 | WO2004022060A3 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 07/08/2004 | WO2004021995A3 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 07/08/2004 | WO2004021983A3 In situ polymerizing medical compositions |
| 07/08/2004 | WO2004019927A3 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation |
| 07/08/2004 | WO2004019909A3 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 07/08/2004 | WO2004019866A3 Compositions and methods for treating cardiovascular disease |
| 07/08/2004 | WO2004018010A3 Methods of drug delivery using sulphated chitinous polymers |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2004017896A3 Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist |
| 07/08/2004 | WO2004014835A9 Resolvins: biotemplates for therapeutic interventions |
| 07/08/2004 | WO2004014322A3 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 07/08/2004 | WO2004012657A3 Beta-glucan containing composites, methods for manufacturing and for using such composites |
| 07/08/2004 | WO2004012653A3 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/08/2004 | WO2004010942A3 Substituted heterocyclic compounds as modulators of the ccr5 receptor |
| 07/08/2004 | WO2004009097A3 Use of a nad analogue, mono-adp-ribosyl transferase substrate and nad antagonist, for preparing a medicine for treating pathologies related to purinergic receptors |
| 07/08/2004 | WO2004009072B1 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | WO2004007498A3 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2004004641A3 PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 07/08/2004 | WO2004004547A3 Method for colpoplasty |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003104396A3 Control of protozoa and protonzoan cysts that harbor legionella |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism |
| 07/08/2004 | WO2003097593A3 Protease inhibitors |
| 07/08/2004 | WO2003093322A9 Carrageenan based antimicrobial compositions |
| 07/08/2004 | WO2003092625A3 Carvedilol formulations |
| 07/08/2004 | WO2003079757A3 Hiv therapeutic |
| 07/08/2004 | WO2003075656A3 Nematicidal fatty acid and fatty acid ester related compounds |
| 07/08/2004 | WO2003074033A8 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003059193A8 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 07/08/2004 | WO2003057187A8 Combinations of viscoelastics for use during surgery |
| 07/08/2004 | WO2003057177A3 Counteracting bioprosthetic calcification |
| 07/08/2004 | WO2003057072A8 Hemostatic compositions and methods for controlling bleeding |
| 07/08/2004 | WO2003057012A3 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 07/08/2004 | WO2003053292B1 Vaginal delivery of drugs |
| 07/08/2004 | WO2003049685A3 Treatment for age-related macular degeneration |
| 07/08/2004 | WO2003042358A3 Methods of using 48149, a human aminopeptidase family member |
| 07/08/2004 | WO2003039553B1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 07/08/2004 | WO2003032941A3 Cosmetic and/or dermatological active ingredient combination |
| 07/08/2004 | WO2003026591A9 Modification of feeding behavior |
| 07/08/2004 | WO2003024965A3 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 07/08/2004 | WO2003020245A8 Residual solvent extraction method and microparticles produced thereby |
| 07/08/2004 | WO2003002058A9 Bone anabolic compounds and methods of use |
| 07/08/2004 | WO2002034203A3 Novel derivatives of phenyl 4-aminosalicylate and method of making the same |
| 07/08/2004 | US20040133030 (Z)-styrylbenzylsulfones and pharmaceutical uses thereof |
| 07/08/2004 | US20040133017 Reducing an unisolable magnesium salt of a benzophenone derivative to form 4-bromo-(2-hydroxymethyl)phenyl-(41-fluorophenyl)methanol, treating with acid catalyst; reacting with copper cyanide, isolation, recrystallization, reacting |
| 07/08/2004 | US20040133013 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 07/08/2004 | US20040133012 For use as anesthetics and as neuroprotective agents; prevents the formation of the toxic metabolite, 2-phenyl-acrylamide |
| 07/08/2004 | US20040133011 Useful for therapy of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 07/08/2004 | US20040133001 Peptide deformylase inhibitors |
| 07/08/2004 | US20040132998 Compositions and methods for separating amines and amino acids from their counter-enantiomers |
| 07/08/2004 | US20040132992 Process for the selective preparation of 3-(z) propenyl-cephem compound |
| 07/08/2004 | US20040132989 Enhancing purity of lactose via demineralization and alcohol precipitation; infant dairy product; veterinary medicine |
| 07/08/2004 | US20040132988 Immunoeffector compounds |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132904 Overcoating medical equipment with nitrosylated cyclodextrin |
| 07/08/2004 | US20040132830 Antiproliferative agents; anticancer agents; antiinflammatory agents; autoimmune diseases |